본문 바로가기 주메뉴 바로가기
  • HOME
  • Company Introduction
  • History

History

2000
  • 2009.11
    Initiated a phase Ⅱ clinical trial for pancreatic cancer
    (Yonsei University Severance Hospital)
  • 2008.11
    Initiated a phase Ⅲ clinical trial for glioblastoma
    (Asan Medical Center, Samsung Medical Center, Yonsei University Severance Hospital, Korea University Anam Hospital, Konkuk University Hospital, Kyunghee University Hospital and Hanyang University Guri Hospital)
  • 2008.06
    Initiated a phase Ⅲ clinical trial for hepatocellular carcinoma
    (Seoul National University Hospital, Asan Medical Center, Samsung Medical Center and Korea University Guro/Ansan Hospitals)
  • 2007.08
    Received approval for the hepatocellular carcinoma
    immunotherapy
    ‘Immuncell-LC’ from MFDS Received approval for a KGMP
    facility
  • 2006.07
    Completed the development of the immunotherapy
    ‘Immuncell-LC’
  • 2006.04
    Acquired a patent on immune cell cryopreservation technology
  • 2003.05
    Started the cord blood cryopreservation business “Dream Cord”
  • 2002.01
    Started research on cancer immunotherapy and cell therapy
    technologies
1990
  • 1998.09
    KOSDAQ Registration (031390)
  • 1992.09
    Company Established